信隆健康(002105) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was CNY 642,194,086.80, representing a slight increase of 0.01% year-over-year, while the year-to-date revenue reached CNY 1,912,457,854.82, up 44.14% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was CNY 77,612,132.80, an increase of 15.22% year-over-year, with a year-to-date net profit of CNY 202,714,366.86, reflecting a significant increase of 79.73%[3]. - The basic earnings per share for Q3 2021 was CNY 0.213, up 15.14% year-over-year, while the diluted earnings per share also stood at CNY 0.213[3]. - Total operating revenue for Q3 2021 reached CNY 1,912,457,854.82, a significant increase of 44% compared to CNY 1,326,787,676.22 in the same period last year[19]. - Operating profit for the period was CNY 244,847,527.01, up from CNY 145,518,249.21, reflecting a growth of 68% year-over-year[19]. - Net profit attributable to the parent company was CNY 202,714,366.86, compared to CNY 112,790,015.98 in the previous year, marking an increase of 79.7%[20]. Assets and Liabilities - The company's total assets as of the end of Q3 2021 were CNY 2,183,508,626.14, which is a 19.00% increase from the end of the previous year[3]. - The total equity attributable to shareholders increased by 20.05% to CNY 785,240,130.59 compared to the end of the previous year[4]. - Total liabilities rose to CNY 1,312,843,300.37, compared to CNY 1,123,520,497.01, indicating an increase of 16.8%[17]. - The company's total assets increased to CNY 2,183,508,626.14, up from CNY 1,834,878,332.28, representing a growth of 19%[17]. Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 110,158,422.51, down 37.67% compared to the previous year[3]. - Operating cash inflow for the period reached CNY 1,986,251,278.68, an increase from CNY 1,437,679,886.97 in the previous period, representing a growth of approximately 38.3%[22]. - Net cash flow from operating activities was CNY 110,158,422.51, down from CNY 176,736,950.25 in the previous period, indicating a decline of about 37.5%[23]. - Cash outflow from investing activities was CNY 90,780,476.35, compared to CNY 35,660,725.31 in the previous period, showing an increase of approximately 154.5%[24]. - Net cash flow from financing activities was -CNY 6,005,841.26, an improvement from -CNY 85,528,874.75 in the previous period, indicating a reduction in cash outflow by about 92.9%[24]. - The total cash and cash equivalents at the end of the period amounted to CNY 393,663,904.91, up from CNY 347,162,806.77 in the previous period, reflecting an increase of approximately 13.4%[24]. Research and Development - The company's research and development expenses increased significantly by 119.34% year-over-year, amounting to CNY 56,134,230.16 for the year-to-date period[9]. - Research and development expenses for the quarter were CNY 56,134,230.16, which is a 119% increase from CNY 25,592,887.19 in the same quarter last year[19]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,866[11]. - The largest shareholder, Litian Development Co., Ltd., holds 41.93% of the shares, totaling 154,522,500 shares[11]. Inventory and Receivables - Accounts receivable rose by 39.77% to CNY 657,457,562.33, attributed to a substantial increase in revenue during the reporting period[8]. - Inventory increased by 34.78% to CNY 402,892,878.45, driven by a rise in orders and a significant increase in raw material prices[8]. - Accounts receivable increased to ¥657,457,562.33 from ¥470,397,763.18 year-over-year[15]. Other Financial Information - The company received CNY 57,665,628.34 in tax refunds, compared to CNY 43,127,381.62 in the previous period, marking an increase of about 33.8%[23]. - Cash received from investment income was CNY 855,455.82, down from CNY 5,099,713.63 in the previous period, representing a decline of approximately 83.2%[24]. - The company paid CNY 90,602,578.96 in dividends and interest, compared to CNY 57,376,398.78 in the previous period, an increase of approximately 57.8%[24].